We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Magnetic Hearing Device Avoids Skin Penetration

By HospiMedica International staff writers
Posted on 02 Jan 2014
Print article
Image: The Baha 4 Attract system (Photo courtesy of Cochlear).
Image: The Baha 4 Attract system (Photo courtesy of Cochlear).
A novel cochlear hearing device creates a pathway for bone conduction hearing, without the need for an abutment that pierces the skin.

The Baha 4 Attract system consists of a titanium implant placed in the mastoid process behind the ear, which allows for transmission of sound vibrations to the inner ear. An advanced sound processor, which uses a front microphone to pick up sounds facing the user and a secondary microphone to filter surrounding noise, sends vibrations to an external magnet, which are transmitted to the internal magnet, which rests under the skin. The internal magnet then relays the vibrations to the titanium implant that is placed in the bone, which in turn transmits the sound waves to the inner ear.

The sound processor uses the Ardium platform, which is three times faster and has eight times more memory than previous generation processors. The added computing power is used to drive sophisticated sound technologies, together with true 2.4 GHz digital wireless connectivity and remote controls. The Baha 4 Attract system is a product of Cochlear (Centennial, CO, USA), and has been approved by the US Food and Drug Administration (FDA).

“The Baha 4 Attract System sets new standards in simplicity, comfort, and hearing performance for magnetic bone conduction implant systems,” said Chris Smith, president of Cochlear. “We are pleased to be bringing this new hearing option to patients who want to enjoy the benefits of the Baha System without a skin penetrating abutment. Cochlear is dedicated to being a leader in bone conduction and this important milestone further emphasizes our commitment to continuing our legacy in innovation.”

In a normal ear, sound vibrations in the air lead to resonant vibrations of the basilar membrane inside the cochlea. The movement of hair cells, located all along the basilar membrane, creates an electrical disturbance that can be picked up by the surrounding nerve cells. The brain is able to interpret the nerve activity to determine which area of the basilar membrane is resonating, and therefore what sound frequency is being heard. The cochlear implant bypasses the hair cells and stimulates the cochlear nerves directly using electrical impulses. This allows the brain to interpret the frequency of sound as it would if the hair cells of the basilar membrane were functioning properly.

Related Links:

Cochlear


Gold Member
12-Channel ECG
CM1200B
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Infant Blood Draw Station
Infant Blood Draw Station

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.